Venture Capital and Infectious Disease Startups: Challenges and Opportunities
Venture capital firms are increasingly investing in startups focused on innovative infectious disease solutions, addressing key regulatory and market challenges while capitalizing on the growing demand for advanced diagnostics and treatments.